Comparison of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of Healthcare Resource Utilization and Relapse Rates from US Insurance Claims Data.

Nicholas, Jacqueline; Boster, Aaron; Wu, Ning; Yeh, Wei-Shi; Fay, Monica; Kendter, Jon; Huang, Ming-Yi; Lee, Andrew

Nicholas, Jacqueline; Boster, Aaron; Wu, Ning; Yeh, Wei-Shi; Fay, Monica; Kendter, Jon; Huang, Ming-Yi; Lee, Andrew.

Afiliação

Nicholas J; OhioHealth Multiple Sclerosis Center, Riverside Methodist Hospital, Columbus, OH, USA.
Boster A; OhioHealth Multiple Sclerosis Center, Riverside Methodist Hospital, Columbus, OH, USA.
Wu N; Biogen, 225 Binney Street, Cambridge, MA, 02142, USA.
Yeh WS; Biogen, 225 Binney Street, Cambridge, MA, 02142, USA.
Fay M; Biogen, 225 Binney Street, Cambridge, MA, 02142, USA.
Kendter J; Biogen, 225 Binney Street, Cambridge, MA, 02142, USA.
Huang MY; Biogen, 225 Binney Street, Cambridge, MA, 02142, USA.
Lee A; Biogen, 225 Binney Street, Cambridge, MA, 02142, USA. andrew.lee@biogen.com.

Pharmacoecon Open ; 2(1): 31-41, 2018 Mar.

Article em En | MEDLINE | ID: mdl-29464673

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Aspecto: Implementation_research Idioma: En Revista: Pharmacoecon Open Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google